SOURCE: Kalorama Information

Kalorama Information

July 26, 2011 10:10 ET

AACC Meeting Issue Highlights Kalorama's Molecular Diagnostic Forecast

NEW YORK, NY--(Marketwire - Jul 26, 2011) - The meeting issue of Clinical Laboratory News, the magazine of the American Association for Clinical Chemistry (AACC), distributed to thousands of lab technicians, lab managers and exhibiting company representatives attending the annual conference in Atlanta, GA this week, features market estimations from healthcare market research publisher Kalorama Information which demonstrate the exceptional growth of molecular diagnostics. The article details the trends driving this growth and the share of key players as the market stood in 2010.

"We are pleased that the AACC Meeting's issue has chosen to focus on some of the same trends we've been informing our readers of over the years, the above-average growth rates seen in this area of diagnostics and the emergence of test service offerings," said Bruce Carlson, Publisher of Kalorama Information.

According to the article in Clinical Laboratory News that features Kalorama Information's market sizing, the market for molecular diagnostics is now thirteen times what it was in 1995. Back then the market stood at $360 million, while today Kalorama estimates it at over $4.7 billion. Kalorama expects growth to continue at a rate of 11% per year, nearly double the growth found in other areas of in vitro diagnostics.

Kalorama Information is a healthcare market research publisher with a particular focus on diagnostic markets. The firm publishes "The World Market for Molecular Diagnostics: Potential and Reality, What's Hot and What's Not," among other reports. Representatives of Kalorama Information will be attending the Clinical Lab Expo, reviewing new offerings and approaches and consulting with companies in the market. You can learn more about Kalorama's market research titles at:

About Kalorama Information

Kalorama Information supplies the latest in independent medical market research in diagnostics, biotech, pharmaceuticals, medical devices and healthcare; as well as a full range of custom research services. We routinely assist the media with healthcare topics. Follow us on Twitter and LinkedIn.

Contact Information